ArticlePLoS neglected tropical diseases2025
Hematological and coagulation alterations and splenic response following Macrovipera lebetina obtusa envenomation: Evaluation of ovine-derived experimental antivenom.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Macrovipera lebetina obtusa (M. l. obtusa) is the most medically significant viper species in Armenia and the region, responsible for the majority of snakebite cases. This study investigated the hematological, coagulation, and histopathological effects of M. l. obtusa envenomation in rats and mice, and evaluated the therapeutic efficacy of an ovine-derived experimental antivenom. Hematological analysis revealed significant increases in red blood cell (RBC) count and hemoglobin (HGB) concentration following envenomation, suggestive of hemoconcentration likely due to vascular leakage. Coagulation studies demonstrated marked prolongation of prothrombin time (PT) and activated partial thromboplastin time (APTT), indicating venom-induced coagulopathy. Notably, PT was more severely affected, and its elevation persisted even after antivenom administration, suggesting incomplete neutralization of venom activity. Histopathological examination of spleen and skin tissues showed progressive structural disruption, including hemorrhage, edema, and lymphoid follicle hyperplasia, which remained evident up to seven days post-envenomation. While the experimental antivenom provided partial systemic protection and improved some hematological parameters, it was unable to reverse the venom-induced tissue and coagulation abnormalities fully. These findings highlight the complex pathophysiology of M. l. obtusa venom and underscore the need for adjunctive therapies targeting vascular integrity and immune regulation in the management of viper envenomation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.